🔎 Trials Near Me

Home › Transthyretin-Related Hereditary Amyloidosis › Massachusetts › Boston

Transthyretin-Related Hereditary Amyloidosis clinical trials in Boston, MA

4 studies for Transthyretin-Related Hereditary Amyloidosis are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis

RecruitingObservational study
  • Research Site, Boston
  • Research Site, Boston
  • Research Site, Boston
Ages 18 to 130 · All sexes · Updated Sep 23, 2026 · NCT06465810

Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF

Recruiting
  • Massachusetts General Hospital, Boston
Ages 65 and older · All sexes · Updated Sep 1, 2026 · NCT05577819

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

RecruitingPhase 3
  • Massachusetts General Hospital, Boston
  • Brigham and Women's Hospital, Boston
  • Boston University (BU) School of Medicine, Boston
Ages 18 to 75 · All sexes · Updated Aug 4, 2026 · NCT06563895

MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

RecruitingPhase 3
  • Brigham and Women's Hospital, Boston
  • Boston University School of Medicine, Boston
Ages 18 to 90 · All sexes · Updated Mar 27, 2026 · NCT06128629

Transthyretin-Related Hereditary Amyloidosis trials in other cities

Other studies in Boston

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.